Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
作者信息
Walton K W, Craig G M, Prior P, Waterhouse J A, Skilton J
出版信息
Br Heart J. 1973 Feb;35(2):211-9. doi: 10.1136/hrt.35.2.211.
Abstract
摘要
相似文献
1
Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).吡啶醇胺用于外周动脉疾病（闭塞性动脉硬化症）的双盲交叉临床试验。
Br Heart J. 1973 Feb;35(2):211-9. doi: 10.1136/hrt.35.2.211.
2
[Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography].[用趾容积描记法分析抗栓丸治疗闭塞性动脉硬化症]
Nihon Naika Gakkai Zasshi. 1970 Feb 10;59(2):117-25. doi: 10.2169/naika.59.117.
3
Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.抗动脉粥样硬化药物吡啶醇胺的临床药理学评价。一项治疗闭塞性动脉硬化的双盲交叉试验。
Am Heart J. 1970 Jan;79(1):5-19. doi: 10.1016/0002-8703(70)90388-1.
4
A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.一项关于吡啶醇胺治疗外周动脉阻塞性疾病患者的临床试验。
Jpn Heart J. 1973 Jan;14(1):12-21. doi: 10.1536/ihj.14.12.
5
Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
Jpn Heart J. 1965 Sep;6(5):407-15. doi: 10.1536/ihj.6.407.
6
Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.用趾容积描记法分析吡啶醇胺对闭塞性动脉硬化症的治疗作用。
Jpn Heart J. 1970 Sep;11(5):433-49. doi: 10.1536/ihj.11.433.
7
[Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
Cas Lek Cesk. 1976 Aug 27;115(33-34):1051-5.
8
Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Ther Hung. 1976;24(2):67-71.
9
[Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].吡啶醇胺（安吉林）对合并脑动脉硬化和外周动脉硬化患者的治疗效果
Neurol Neurochir Pol. 1978 Jul-Aug;12(4):387-96.
10
[Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].[用抗栓丸治疗的周围动脉病患者的临床及体积描记法评估]
Prensa Med Argent. 1970 Apr 24;57(8):394-8.
本文引用的文献
1
AORTOGRAPHY IN THE INVESTIGATION OF HYPERTENSION.高血压研究中的主动脉造影术。
Lancet. 1965 Mar 20;1(7386):619-21. doi: 10.1016/s0140-6736(65)91712-5.
2
The measurement of volume changes in human limbs.人体四肢体积变化的测量。
J Physiol. 1953 Jul;121(1):1-27. doi: 10.1113/jphysiol.1953.sp004926.
3
The effect of hyperosmolarity on intacet and isolated vascular smooth muscle. Possible role in exercise hyperemia.高渗对完整及分离的血管平滑肌的影响。在运动性充血中的可能作用。
Angiologica. 1967;4(6):310-22. doi: 10.1159/000157715.
4
The natural history of atherosclerosis. Comparison of aortic lesions in Tokyo, New Orleans, Guatemala and Costa Rica.动脉粥样硬化的自然史。东京、新奥尔良、危地马拉和哥斯达黎加主动脉病变的比较。
J Atheroscler Res. 1966 Mar-Apr;6(2):107-19. doi: 10.1016/s0368-1319(66)80016-9.
5
Pyridinolcarbamate, a bradykinin antagonist in veins. A preliminary report on pharmacologic and clinical observations.吡啶醇氨基甲酸酯，一种静脉中的缓激肽拮抗剂。药理学和临床观察的初步报告。
Am Heart J. 1966 Mar;71(3):297-312. doi: 10.1016/0002-8703(66)90469-8.
6
The computer in the laboratory.实验室里的电脑。
Practitioner. 1969 Sep;203(215):294-505.
7
The natural course of peripheral arteriosclerosis obliterans evaluated by flow measurements.通过血流测量评估的外周动脉硬化闭塞症的自然病程。
Angiology. 1969 Jul;20(7):414-21. doi: 10.1177/000331976902000705.
8
Serial aortography in the study of peripheral vascular disease--a clinical-radiological study.外周血管疾病研究中的系列主动脉造影——一项临床放射学研究
Br J Radiol. 1968 May;41(485):333-40. doi: 10.1259/0007-1285-41-485-333.
9
Contraction frequency, blood supply, and muscle pain.收缩频率、血液供应和肌肉疼痛。
J Appl Physiol. 1968 Feb;24(2):142-5. doi: 10.1152/jappl.1968.24.2.142.
10
[Seasonal changes in bradykinin sensitivity in the rabbit and the rat].[兔和大鼠中缓激肽敏感性的季节性变化]
Boll Soc Ital Biol Sper. 1969 Apr 15;45(7):421-3.
Zotero 插件